🔗 Permalink

Inventor profile of:

William Querbes

City:

Boston, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2025-04-17

Top Assignees for applications by William Querbes

The entities that hold a legal rights for patent applications filed by inventor Querbes William:

ALNYLAM PHARMACEUTICALS, INC. 27 Cambridge, MA United States
Dana-Farber-Cancer Institute, Inc. 1 Boston, MA United States

Recent patent applications by Querbes William

William Querbes from Boston, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-04-17

US20250122505A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

#2 | 2025-02-27

US20250064936A1

Human necessities

COMPOSITIONS AND METHODS FOR INHIBITION OF HAO1 (HYDROXYACID OXIDASE 1 (GLYCOLATE OXIDASE)) GENE EXPRESSION

#3 | 2025-02-13

US20250051765A1

Chemistry; metallurgy

APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

#4 | 2025-01-30

US20250034566A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

#5 | 2024-08-01

US20240254486A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

#6 | 2024-06-20

US20240200075A1

Chemistry; metallurgy

ANGIOPOIETIN-LIKE 3 (ANGPTL3) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

#7 | 2024-05-30

US20240175030A1

Chemistry; metallurgy

ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

#8 | 2023-04-20

US20230121944A1

Human necessities

COMPOSITIONS AND METHODS FOR INHIBITION OF HAO1 (HYDROXYACID OXIDASE 1 (GLYCOLATE OXIDASE)) GENE EXPRESSION

#9 | 2023-03-02

US20230068339A1

Chemistry; metallurgy

APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

#10 | 2023-01-05

US20230002772A1

Chemistry; metallurgy

PCSK9 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

#11 | 2022-07-28

US20220235358A1

Chemistry; metallurgy

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

#12 | 2022-04-21

US20220119815A1

Chemistry; metallurgy

ANGIOPOIETIN-LIKE 3 (ANGPTL3) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

#13 | 2022-03-10

US20220073929A1

Chemistry; metallurgy

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

#14 | 2022-03-10

US20220073928A1

Chemistry; metallurgy

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

#15 | 2022-03-10

US20220073927A1

Chemistry; metallurgy

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

#16 | 2022-03-10

US20220073926A1

Chemistry; metallurgy

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

#17 | 2022-03-10

US20220073925A1

Chemistry; metallurgy

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

#18 | 2022-03-10

US20220073924A1

Chemistry; metallurgy

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

#19 | 2021-06-10

US20210171955A1

Chemistry; metallurgy

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

#20 | 2021-06-10

US20210171954A1

Chemistry; metallurgy

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

#21 | 2021-04-15

US20210108203A1

Chemistry; metallurgy

Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof

#22 | 2020-10-08

US20200316201A1

Human necessities

Compositions and methods for inhibition of HAO1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression

#23 | 2020-07-16

US20200224201A1

Chemistry; metallurgy

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

#24 | 2020-06-25

US20200199591A1

Chemistry; metallurgy

Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof

#25 | 2020-05-07

US20200140866A1

Chemistry; metallurgy

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

#26 | 2020-03-12

US20200080088A1

Chemistry; metallurgy

APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

#27 | 2019-11-21

US20190352645A1

Chemistry; metallurgy

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

#28 | 2019-10-17

US20190316137A1

Chemistry; metallurgy

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

#29 | 2018-03-29

US20180087054A1

Chemistry; metallurgy

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

#30 | 2017-12-14

US20170355994A1

Chemistry; metallurgy

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

#31 | 2017-10-26

US20170304446A1

Human necessities

Compositions and methods for inhibition of HAO1 (Hydroxyacid Oxidase 1 (Glycolate Oxidase)) gene expression

#32 | 2017-09-14

US20170260527A1

Chemistry; metallurgy

Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof

#33 | 2016-06-30

US20160186180A1

Chemistry; metallurgy

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

#34 | 2016-06-23

US20160177313A1

Chemistry; metallurgy

Compositions and methods for increasing erythropoietin (EPO) production

#35 | 2016-01-21

US20160017335A1

Chemistry; metallurgy

PCSK9 iRNA compositions and methods of use thereof

#36 | 2014-06-26

US20140179768A1

Chemistry; metallurgy

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

InventorID:

816266 ⎘